Jill Charlotte Anderson sold $514k of EIX
EXECUTIVE VICE PRESIDENT, SCE at EDISON INTERNATIONAL. 6,885 shares at an average of $74.67, traded Feb 27, 2026, filed Mar 3, 2026.
Score components
- +15RoleOfficer
- +18Trade size$514k at market
- +10Share of holdings soldSold 29% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001787198-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | MOption exercise Common Stock | +20,471 | $54.91 | $1.1M | 39,063 | Mar 3, 2026 |
| Feb 27, 2026 | FTax withholding Common Stock | -16,978 | $74.83 | $1.3M | 22,085 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Common Stock | +13,386 | $63.65 | $852k | 35,471 | Mar 3, 2026 |
| Feb 27, 2026 | FTax withholding Common Stock | -12,105 | $74.83 | $906k | 23,366 | Mar 3, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock | -4,774 | $74.72 | $357k | 18,592 | Mar 3, 2026 |
| Mar 2, 2026 | MOption exercise Common Stock | +8,720 | $60.78 | $530k | 27,312 | Mar 3, 2026 |
| Mar 2, 2026 | FTax withholding Common Stock | -7,682 | $74.65 | $573k | 19,630 | Mar 3, 2026 |
| Mar 2, 2026 | MOption exercise Common Stock | +10,296 | $62.50 | $644k | 29,926 | Mar 3, 2026 |
| Mar 2, 2026 | FTax withholding Common Stock | -9,223 | $74.65 | $688k | 20,703 | Mar 3, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock | -2,111 | $74.55 | $157k | 18,592 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Non-qualified Stock Options (Right to Buy)derivative | -20,471 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Feb 27, 2026 | MOption exercise Non-qualified Stock Options (Right to Buy)derivative | -13,386 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 2, 2026 | MOption exercise Non-qualified Stock Options (Right to Buy)derivative | -8,720 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 2, 2026 | MOption exercise Non-qualified Stock Options (Right to Buy)derivative | -10,296 | $0.00 | $0 | 0 | Mar 3, 2026 |
Related signals
Other insiders at EDISON INTERNATIONAL and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | EDISON INTERNATIONAL | Peter J. Taylor director | $38k 500 shares | -1% | |
| 16Weak | EDISON INTERNATIONAL | Peter J. Taylor director | $37k 500 shares | -1% | |
| 35Weak | EDISON INTERNATIONAL | Erica S Bowman VICE PRESIDENT | $94k 1,276 shares | -28% | |
| 25Weak | EIXsell EDISON INTERNATIONAL | Peter J. Taylor director | $99k 1,800 shares | -5% | |
| 55Moderate | EIXsell EDISON INTERNATIONAL | J Andrew Murphy PRESIDENT & CEO, EDISON ENERGY | $648k 11,900 shares | -43% | |
| 47Moderate | EIXsell EDISON INTERNATIONAL | Jeanne Beliveau-Dunn director | $179k 3,288 shares | -100% | |
| 23Weak | EDISON INTERNATIONAL | Erica S Bowman VICE PRESIDENT | $42 0 shares | -0% | |
| 40Moderate | EDISON INTERNATIONAL | Peter J. Taylor director | $104k 1,250 shares | -4% | |
| 30Weak | EDISON INTERNATIONAL | Keith Trent director | $78 1 shares | -0% | |
| 37Weak | EDISON INTERNATIONAL | Maria C. Rigatti EXEC. VP AND CFO | $75 1 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.